Cite
HARVARD Citation
Dadjou, Y. et al. (2016). Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting. Medicine. 95 (22), pp. e3663-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dadjou, Y. et al. (2016). Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting. Medicine. 95 (22), pp. e3663-. [Online].